Biomarker With Neurodegeneration Patients Clinical Trial
Official title:
Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients
Using to method of Proteomics, for aims to conquer intractable disease, try to access variety experiment. Biomarker is necessary to develop new diagnosis method and target of treatment.
Following Seoul National University Hospital Institutional Review Board approval, obtain serum and platelet with neurodegeneration patients and control group visited the part of neurology, there'll be analysis to differentiate each other diseases use to method Proteomics. Biomarker will be screening via 1D/2D analysis, Mass analysis, database searching- the MASCOT search tool, SWISS-PROT and etc. ;
Observational Model: Cohort, Time Perspective: Retrospective